EDQM · Programme report
EDQM highlights international API inspection cooperation report
Official source date: · Source checked
EDQM highlights the 2017–2024 International API Inspection Programme report, describing information sharing and joint inspections among 13 authorities to strengthen GMP oversight and reduce duplication.
Who should review this?
API manufacturers, supplier-qualification teams and inspection-readiness leads.
What it means for pharmaceutical teams
The report concerns collaboration between authorities, including inspection planning and outcomes. It provides background for oversight discussions; supplier qualification still needs evidence about the actual manufacturing site.
Practical review checklist
PharmaEdges reading prompts for your own applicability review:
- Read the report scope and participating-authority information.
- Keep programme findings separate from individual supplier inspection evidence.
- Review applicable supplier qualification records through your quality system.
Official source and verification
Read the EDQM source (opens in a new tab)
This article summarises the linked official material. The context and checklist are PharmaEdges explanatory commentary, not additional regulatory requirements. The source publication date is separate from this article’s publication date.
For a correction, contact PharmaEdges with the article URL and supporting source. Read our news publishing policy.
Related regulatory news
- EMA PRAC opens reviews of Deanxit and immunoglobulin safety reports
- CDSCO issues notice on raw-material and finished-formulation testing
- CDSCO lists ONDLS monitoring notice for high-risk solvent supply chains
- EMA announces permanent clinical-trial application advice from January 2027
- EMA publishes year-end 2026 advice for type I variation submissions